For many years, Oracle databases have served as the foundation for scientific data management platforms across pharmaceutical, biotechnology, CRO, and research organizations. Their reliability, scalability, and enterprise-grade capabilities made them a natural choice for managing critical scientific data and workflows.
However, the technology landscape is changing.
Today, many organizations are reassessing their database strategies as they balance operational efficiency, infrastructure costs, and long-term digital transformation goals. As a result, open-source alternatives such as PostgreSQL are becoming increasingly attractive for research organizations looking to modernize their scientific software environments.
The Challenge Facing Research Organizations
Research informatics platforms are often deeply embedded within scientific workflows. They manage valuable experimental data, inventory, protocols, study information, assay results, and reporting processes that have evolved over many years.
While organizations recognize the need to modernize their infrastructure, they also face a significant challenge:
How can they reduce technology costs and modernize their systems without disrupting scientific workflows?
For many organizations, database licensing costs have become an increasingly important consideration. At the same time, IT teams are being asked to simplify infrastructure, improve maintainability, and support future cloud-based deployment strategies.
This creates a difficult balance between innovation and operational stability.
The Rise of PostgreSQL in Scientific Computing
PostgreSQL has emerged as one of the most widely adopted open-source database platforms in the world.
Organizations across multiple industries are leveraging PostgreSQL because it offers:
- Enterprise-grade performance and reliability
- Strong security capabilities
- Active community and ecosystem support
- Flexibility for modern deployment environments
- Reduced licensing costs compared to traditional commercial databases
For research organizations, PostgreSQL provides an opportunity to modernize infrastructure while maintaining the integrity and accessibility of valuable scientific data.
Modernization Without Reinvention
One of the biggest concerns during any technology migration is disruption.
Scientists, laboratory managers, and informatics teams are not looking to redesign their workflows every time infrastructure changes. Their priority is maintaining productivity while reducing risk.
This is why modernization initiatives are increasingly focused on preserving existing workflows while updating the underlying technology stack.
The goal is to provide a more sustainable and future-ready platform beneath those workflows.
Supporting the Next Generation of Research Platforms
Modern scientific organizations are increasingly exploring:
- Cloud and hosted deployments
- Improved integration capabilities
- Scalable data management strategies
- Advanced analytics and reporting
- Emerging research approaches such as New Approach Methodologies (NAMs)
Supporting these initiatives requires a technology foundation that can evolve alongside scientific innovation.
As organizations continue their digital transformation journeys, database modernization is becoming an important step toward building flexible, scalable, and future-ready research environments.
BioRails: The Shift is Already Underway
Instem’s BioRails® platform is a practical example of this modernization path in action. Built for workflow management across drug discovery research, BioRails now runs on PostgreSQL, giving scientific organizations a proven way to move off legacy Oracle infrastructure without reworking the study workflows their teams already rely on.
The strategy is built around two phases.
Phase 1: BioRails 6.4 → BioRails 7.0 (on Oracle)
Existing customers move onto the latest BioRails platform while staying on Oracle. This phase focuses on:
- Modernizing the underlying technology stack
- Improving security and supportability
- Strengthening long-term maintainability
- Preserving existing workflows and user experience
Phase 2: BioRails 7.0 → PostgreSQL
Once customers are on BioRails 7.0, they can migrate from Oracle to PostgreSQL. This step delivers:
- Reduced dependency on Oracle licensing and infrastructure costs
- A modern, open-source database platform
New customers can skip this journey entirely. BioRails 7.0 on PostgreSQL is available to them from day one.
What’s Changed Behind the Scenes
The user experience has intentionally stayed the same throughout. But underneath, the platform has been rebuilt with:
- Support for PostgreSQL as a strategic database platform
- An updated technology stack and infrastructure
- Enhanced security and platform support
- Improved long-term maintainability
- Alignment with modern operating system and deployment requirements
- A foundation for future cloud-hosted and SaaS offerings
A Low-Risk Path to PostgreSQL
To support Oracle customers making the move, a dedicated migration tool is in development. It includes:
- Automated data migration from Oracle to PostgreSQL
- Data integrity validation and verification
- Row count and record reconciliation checks
- Primary key and sequence validation
- Migration reporting and audit logs
- Error handling and recovery mechanisms
- Migration comparison and verification reporting
The goal: a repeatable, reliable, and low-risk migration pathway to PostgreSQL.
Perspectives d'avenir
The research landscape continues to evolve rapidly. Organizations are under pressure to manage larger volumes of data, support increasingly complex workflows, and adapt to changing regulatory and operational requirements.
Modernizing scientific data management platforms is way beyond an IT exercise. It is becoming a strategic business decision.
For organizations evaluating the future of their research platforms, the conversation is no longer just about databases.
It is about creating a foundation that enables scientific innovation for years to come.
As more organizations review their technology strategies, the shift toward modern, flexible, and cost-effective platforms is likely to continue accelerating across the life sciences industry.
Ready to see it for yourself?
Explore how BioRails® can help your organization synchronise its discovery research without disrupting the science: Book a Meeting
By Revanth Rayasam,
Product Manager – BioRails
